Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Observer-Blind, Dose-escalation Phase I/II Clinical Trial of Ad5-nCoV Vaccine in Healthy Adults From 18 to <85 Years of Age in Canada

NCT04398147 is registered in ClinicalTrials.gov with CanSino Biologics Inc. as lead sponsor.

NCT NCT04398147
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04398147 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Observer-Blind, Dose-escalation Phase I/II Clinical Trial of Ad5-nCoV Vaccine in Healthy Adults From 18 to <85 Years of Age in Canada
Lead sponsor
CanSino Biologics Inc.
Phase
Phase 1/2
Overall status
Unknown status
Start date
August 1, 2020
Completion date
December 30, 2021
Enrollment
696 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19